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Summary Background. Cosmetic products contribute considerably to the incidence of contact
dermatitis. In response to a resolution of the Council of Europe, the National Institute for
Public Health and the Environment (RIVM) in The Netherlands set up a pilot project to
report undesirable effects attributed to cosmetic products.
Objectives. To provide an overview of undesirable effects attributed to cosmetic
products and to identify the ingredients involved. The information could contribute
to the assessment of whether current EU legislation on cosmetics provides adequate
protection.
Patients/methods. General practitioners, dermatologists and consumers in The
Netherlands completed questionnaires on reported undesirable effects of cosmetics.
Dermatologists also carried out patch tests and, where necessary, tests with specific
batch ingredients of the associated cosmetic product. A website and a public awareness
campaign were launched to encourage consumers to report undesirable effects.
Results. Between July 2009 and May 2011, the RIVM received more than 1600
reports. Severe undesirable effects were claimed in 1–4% of the cases. The most
frequently reported cosmetic products were make-up and moisturisers, and the most
frequently identified allergens were isothiazolinones and fragrance ingredients. Three
patients tested positive for co-polymers/cross-polymers.
Conclusions. Further investigations are recommended on the prevalence of
isothiazolinone-induced allergic contact dermatitis and the allergenic potential of co-
polymers/cross-polymers.
Key words: allergic contact dermatitis; co-polymers/cross-polymers; cosmetic
products; cosmetovigilance; isothiazolinones; monitoring; undesirable effects.
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Cosmetic products cover a wide range of hygiene and
personal care products, including bath and shower
products, fragrances, deodorants, and skin creams. Most
people make use of cosmetic products on a daily basis: for
hygiene, suchas soap; for beautification, suchasmake-up
and hair dyes; or for protection, such as sunscreen and
toothpaste.
In Europe, the safety of cosmetic products is regulated
by the Cosmetic Products Directive (76/768/EEC), which
is to be replaced by the Cosmetic Products Regulation (EC
No. 1223/2009) in July 2013 (1, 2). This legislation
requires manufacturers to ensure the safety of their
cosmetic products in normal use and under reasonably
foreseeable conditions, and national market surveillance
authorities to monitor compliance with the regulation.
EU legislation and enforcement notwithstanding,
consumers may encounter undesirable effects after using
cosmetic products. These effects are mainly localized
on the skin, and include symptoms such as erythema,
itching, scaling, and a burning sensation. Although
rare, severe reactions may also occur, such as burns,
blistering, hair loss, or even loss of consciousness. The
most common undesirable effects are irritant contact
dermatitis and allergic contact dermatitis (3–5). In
particular, fragrances and preservatives in cosmetics
have contributed considerably to the incidence of allergic
contact dermatitis (6–9).
As undesirable effects of cosmetic products may
lead to acute and chronic health impairment, the
Council of Europe adopted a resolution in 2006
recommending that the Member States implement a
system for registering undesirable effects of cosmetic
products (cosmetovigilance) directed to protecting public
health (6). In response, the Netherlands Food and
Consumer Product Safety Authority (NVWA) requested
the National Institute for Public Health and the
Environment (RIVM) to initiate a pilot project to register
and evaluate reports of undesirable effects of cosmetic
products. The pilot project with the acronym CESES
(Consumer Exposure, Skin Effects and Surveillance) is
aimed at providing an overview of undesirable effects
attributed to cosmetic products. These data could
contribute to the assessment of whether current EU
legislation on cosmetics provides adequate protection.
The project collected reports on undesirable effects
of cosmetic products, identified the products and
ingredients causing the undesirable effects, and alerted
the NVWA in cases of a potential health concern.
Furthermore, theprojectprovideda forumfor information
exchange by stakeholders, including consumers, general
practitioners (GPs), dermatologists, government agents,
and inspectorates (10).
In this article, the authors describe how the CESES
projectwas setup,andprovideanoverviewof the reported
undesirable effects attributed to cosmetic products in the
period between July 2009 and May 2011.
Patients and Methods
Participating GPs and dermatologists
Undesirable reactions to cosmetic products were regis-
tered by GPs and dermatologists in the period between
July 2009 and May 2011. The GPs participate in the
Continuous Morbidity Registration (CMR) Sentinel GP
Network of the Netherlands Institute for Health Services
Research (NIVEL). The Dutch CMR Sentinel GP Network
comprises 61 GPs in 42 general practices, representative
of age, sex, geographical distribution and population den-
sity in The Netherlands. The patients registered in these
practices account for 0.8% of the Dutch population, and
are distributed evenly throughout the country1. In the
last 2 years, the sentinel GPs reported regularly on the
occurrenceofundesirableeffectsof cosmeticproducts (11,
12). Dermatologists also contributed to the CESES pilot
project. In July 2009, four dermatological centres partic-
ipated and three more centres joined in July 2010. These
participating dermatological centres included academic
hospitals (VUMC, UMCG, and UMCU), peripheral hospi-
tals (St Antonius Hospital, Reinier de Graaf Hospital, and
Deventer Hospital), and a referral centre for occupational
skin diseases (Centrum voor Huid en Arbeid). The cen-
tres were spread over The Netherlands, and covered both
highly urbanized and more rural parts of the country.
For diagnostic purposes and to identify potential causes of
undesirable effects, dermatologists performed patch tests
with the European baseline series [plus some additional
substances, including methylisothiazolinone (MI) at a
concentration of 0.05% aqua], cosmetic products used,
and, when necessary, specific cosmetic test series. Patch
testpreparationswereappliedontheupperpartof theback
for 2 days (48 hr) with Van der Bend square chambers
(Brielle, TheNetherlands)with Fixomull stretch (Beiers-
dorf, Germany). Readingswere performedonday 2, day 3
and (in somecases) day 6orday 7, andconductedbywell-
trained dermatologists according to the guidelines of the
International Contact Dermatitis ResearchGroup.Where
the outcome of the standard patch tests was not sufficient
to identify the cause of an undesirable effect, the derma-
tologists requested the NVWA to obtain specific batch
ingredients of the cosmetic product from the company
responsible for bringing the product to the market.
1 See also www.nivel.nl.
© 2013 John Wiley & Sons A/S
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Public route Consumers 1294 9 91 41 (0–92) 26 39
Clinical route General practitioners 153 18 82 41 (0–86) 25 20
Dermatologists 163 22 78 40 (6–86) 15 32
Consumer reports
The CESES project also included consumer reports of
undesirable reactions to cosmetic products. Consumer
reports were collected via an online questionnaire on a
dedicated website2 launched by the RIVM. Consumers
could also use the NVWA call centre3 and report
undesirable effects of cosmetic products by telephone.
To create consumer awareness, a media campaign
was conducted that included activities such as news
interviews (newspapers, radio, and television), online
banner advertising, articles in women’s magazines, and
handouts at fairs and conventions.
Questionnaire
All participants (GPs, dermatologists, and consumers)
were asked to complete a questionnaire aboutundesirable
effects of cosmetic products. The questionnaire included:
(i) general personal information (age, sex, occupation,
and familiarity with underlying skin disorders and aller-
gies); (ii) description, body regionand severity of theunde-
sirable reactions; (iii) diagnosis and treatment; and (iv) a
detailed description of the cosmetic product(s) potentially
responsible for the reaction, including brand name, prod-
uct name, batch code, expiration date, and selling point.
In addition, specific questions were asked of each
group of participants. Consumers were asked whether
they had visited a GP or dermatologist. GPs were asked
whether they had referred the patient to a dermatologist.
The dermatologists were asked to record the outcome of
patch tests with the European baseline series, and, where
applicable, the test resultswith batch-specific ingredients.
These reports were checked by a senior dermatologist for
completeness. The potential causal relationship between
the undesirable effect and the cosmetic product was
established according to the COLIPA (now known as
Cosmetics Europe) model (13, 14).
Assessment
All reports were analysed by the RIVM. Those reports
without detailed information on the cosmetic product
2 www.cosmeticaklachten.nl. (in Dutch)
3 Telephone number: +31 800 0488.
or that did not concern a cosmetic product were elimi-
nated. Cases of severe undesirable effects, including hair
loss, blistering, breathing problems, loss of consciousness,
dizziness, skin burns, and nausea, or a high frequency of
undesirable effects attributed to the same cosmetic prod-
uct, were reported to the national competent authority.
Results
Reported cases
In the period between July 2009 and May 2011, a
total of 1294 cases of undesirable effects of cosmetic
products were reported by consumers, 153 cases were
reported by sentinel GPs, and 163 cases were reported
by participating dermatologists (Table 1). In total, 38%
(n = 494) of consumers who reported an adverse skin
reaction after using a cosmetic product visited their
GP, and 12% (n = 158) consulted a dermatologist for
further treatment and/or diagnostic patch testing. Before
givingconsiderationtoconsultingadoctor,aconsiderable
number of consumers (62%, n = 797) had applied self-
treatment, such as treating the affected skin with a
soothing (fatty) cream. The data show that 17% (n =
205) of consumers reported the problem to the product
retailer, and 10% (n = 120) contacted themanufacturer.
In most cases, manufacturers were apparently unaware
of adverse skin reactions caused by cosmetic products.
Furthermore, the number of consumer reports increased
after eachevent in themediacampaign launched tocreate
consumer awareness (data not shown).
Far more adverse reactions were reported by women
(78–91% of reports) than by men. The average age was
∼41 years (Table 1), but reports were received for all
ages, with the youngest person being <1 year old and
the oldest person 92 years old. A considerable number of
people (15–26%) who reported an adverse reaction were
familiar with an underlying skin disease, such as con-
tact eczema or atopic dermatitis, and 20–39% reporting
having an underlying allergy (e.g. pollen, metals, or food
allergens; Table 1).
Localisation and symptoms
Undesirable reactions to cosmetic products were reported
in various body regions, and occurred simultaneously
© 2013 John Wiley & Sons A/S
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Fig. 1. Localisation of undesirable reactions to cosmetic products
reported by consumers, sentinel general practitioners, and
dermatologists.
at several locations. Reports from consumers, sentinel
GPs and dermatologists showed that most undesirable
reactions attributed to cosmetic products occurred on
or around the eyes and eyelids, and on the face and
neck (Fig.1). More undesirable reactions on the hands
were reported by dermatologists (17%, n = 49) than by
consumers and sentinel GPs. Generally, the body regions
affected were directly related to the application site of
the product. Most reported symptoms included erythema
and itching (Fig. 2). Pain was reported in 2% and 6%
of the cases reported by dermatologists and consumers,
respectively. Severe undesirable effects, including hair
loss, blistering, breathing problems, dizziness, skin burns,
and nausea, were claimed in 1–4% of the cases reported.
Loss of consciousness was reported in two cases: one case
was reported by a GP and concerned a hair dye product,
and the other case was reported by a dermatologist and
concerned a hair bleach product. Undesirable effects were
shown to develop quickly, and occurred within 30 min in
16%(n = 202)of the consumer reports and in6%(n = 8)
of the reports byGPs.Most reports fromdermatologists did
not include information on the time elapsed between the
moment of exposure and the development of undesirable
effects.
Reported product categories
The most frequently reported product categories were
make-up and moisturisers (Fig. 3). Undesirable effects

















Fig. 2. Undesirable reactions to cosmetic products reported by
consumers, sentinel general practitioners, and dermatologists.
of make-up products were predominantly reported by
consumers and GPs, and mainly concerned products
designed for use on or around the eyes, such as mascara,
eye shadow, and eyemake-up remover.Moisturiserswere
mainly leave-on body and face care products such as
body lotions/creams and day and night creams. In total,
13% (n = 42) of consumer reports on face care products
concerned eye contour creams, and 12% (n = 8) of
moisturisers reported by dermatologists concerned non-
perfumed ointments.
Dermatologists reported more cases than consumers
and GPs of undesirable effects of hair care products (23%,
n = 51) and soaps (22%, n = 49). Hair care products
were predominantly shampoos (82%, n = 42), and bath
and shower products constituted 61% (n = 30) of reports
onsoaps.Hairdyeproducts responsible for themost severe
undesirable effects encompassed 4% (dermatologists) to
6% (GPs) of the total number of reports (Fig. 3). Although
fragrance ingredients are known allergens in cosmetic
products, hydroalcoholic products such as perfumeswere
mentioned as a potential cause of undesirable effects in
only 2–3% of cases reported.
Patch test results
In 96% (n = 156) of cases reported by dermatologists,
a patch test with the European baseline series was
performed. Most patients (97%, n = 151) tested posi-
tive for one or more allergens or substances/products
(Table 2). The most commonly reported allergens in
these patients were isothiazolinones (23%), fragrance
mix I (21%), cocamidopropyl betaine (CAPB; 21%),
© 2013 John Wiley & Sons A/S
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Fig. 3. Product categories reported to cause undesirable effects registered by consumers, general practitioners, and dermatologists.
and fragrance mix II (18%). The hair dye ingredi-
ent p-phenylenediamine and the fragrance ingredient
hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC)
caused positive reactions in 9% and 6% of the tested
patients, respectively. The preservatives quaternium-15
and formaldehyde, which is also a marker of contact
allergy to formaldehyde releasers, caused positive reac-
tions in 4% and 3% of the tested patients, respectively.
On the basis of these test results, the causal relation-
ships between theundesirable effects and specific cosmetic
products were assessed. In cases where the allergen that
tested positive was found to be an ingredient in the cos-
metic product, a causal relationship between the reported
reaction and the cosmetic product was assessed as being
likely or very likely (Table 2). In those cases where the
product did not contain the allergen that tested positive,
a causal relationship was unlikely. However, a direct
causal relationship between the positively tested allergen
and the cosmetic product could not be confirmed in cases
where the product ingredient lists were not provided
and the dermatologist had not provided a clarification
for the assumed causality. A causal relationship between
the cosmetic product and the undesirable effect was not
assumed in cases of positive test results for allergens, such
as nickel sulfate,methyldibromo glutaronitrile (MDBGN),
and cobalt chloride. These positive test results should be
interpretedwith caution, because these allergens are pro-
hibited in cosmetic products under the Cosmetic Products
Directive (76/768/EEC).
Dermatologists requested specific batch ingredients of
cosmetic products used by 62 patients (38%). However,
the NVWA was able to obtain the requested ingredients
from themanufacturer for only 20 patients (32%). Fifteen
patients (75%) tested positive for one or more batch
ingredients, including surfactants/emulsifiers (n = 7),
fragrance ingredients (n = 4), and preservatives (n = 3).
Three of the 15 patients who tested positive developed
a reaction to co-polymers/cross-polymers, including
C30–38 olefin/isopropyl maleate/MA co-polymer used
in a sunscreen.
Diagnosis
On the basis of the medical history and the results of
diagnostic patch testing, patients were most frequently
diagnosed with allergic contact dermatitis (56%, n = 86)
or a combination of allergic contact dermatitis and atopic
dermatitis (19%, n = 29). Fourteen (9%) patients were
diagnosed with a combination of allergic and irritant
contact dermatitis. None of the patients was diagnosed
with irritant contact dermatitis alone.
Causality assessment and notifications
Assessment of the relationship between undesirable
effects and cosmetic products showed that causality
was unlikely, questionable or unknown in 18% of cases
(n = 30) reported by dermatologists, but was confirmed
and assessed as likely in 52% of cases (n = 84) and very
likely in 30% of cases (n = 49).
TheRIVMnotified theNVWAabout a specific cosmetic
product in six cases. In these cases, theRIVMhad received
a considerable number of reports on a specific batch of
© 2013 John Wiley & Sons A/S
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Table 2. Allergens in the European baseline series (plus some additional substances) to which participants tested positive
Causality assessment
Allergen
% of patients who
tested positive (n)
% likely or




Isothiazolinones (MI or MCI/MI mix) 23 (34) 47 (16) 53 (18) 0 (0)
Fragrance mix I 21 (31) 52 (16) 29 (9) 19 (6)
Cocamidopropyl betaine 21 (32) 63 (20) 25 (8) 13 (4)
Nickel sulfate∗ 20 (30) NA NA NA
Fragrance mix II 18 (27) 41 (11) 37 (10) 22 (6)
Methyldibromo glutaronitrile∗ 13 (20) NA NA NA
p-Phenylenediamine 9 (13) 38 (5) 46 (6) 15 (2)
Colophonium 7 (10) 10 (1) 50 (5) 40 (4)
Cobalt chloride∗ 7 (10) NA NA NA
Hydroxyisohexyl 3-cyclohexene carboxaldehyde 6 (9) 67 (6) 11 (1) 22 (2)
Quaternium-15 4 (6) 17 (1) 50 (3) 33 (2)
Formaldehyde 3 (5) 20 (1) 20 (1) 60 (3)
MCI, methylchloroisothiazolinone; MI, methylisothiazolinone; NA, not assumed.
Data are presented as percentages of the total number of patients who tested positive (n = 151).
∗Ingredients prohibited in cosmetic products in Europe.
a cosmetic product, or the seriousness of the undesirable
effects reported required the RIVM to alert the NVWA.
In response, the NVWA contacted the manufacturer or
importer in The Netherlands to carry out an inspection
of the safety dossier. The inspections did not lead to
product withdrawals from the market. In one case, the
manufacturer considered product reformulation.
Discussion
As cosmetic products have a global market, the CESES
results were compared with the results from other cosme-
tovigilance systems in the EU. Cosmetovigilance systems
are or have been operational in Norway, Sweden, Bel-
gium, Denmark, Germany, France, and Italy (3, 15–21).
Cosmetovigilance systems vary with regard to: (i) the
method of registration (voluntary or legal requirement);
(ii) the participants (dermatologists, pharmacists, den-
tists, or consumers); and (iii) agencies responsible for
the cosmetovigilance system (government, public health
agency, consumer organisation, or industry).
To the best of our knowledge, the CESES project is the
first cosmetovigilance system that also includes a specific
website dedicated to the collection of consumer reports.
Even though these reports are not validated by medical
professionals, andarebasedonconsumerperception, they
provide insights into the occurrence of undesirable effects
of cosmetic products, and are early signals for attention to
a specific cosmetic product or ingredient. Since 2003, the
Netherlands Pharmacovigilance Centre (Lareb) has also
been accepting patient reports on undesirable effects of
drugs. Lareb has recently reported that consumer reports
providedavaluable contribution inaddition tohealthcare
professional reports (22).
From the start of the CESES project in July 2009
until May 2011, the RIVM received more than 1600
reports (∼ 73 reports/month) of undesirable effects of
cosmetic products. From the reports of the sentinel GPs,
it is estimated that 13 in 10 000 people or ∼22 000
individuals in The Netherlands (considering 16.7 million
registered inhabitants) consult a GP about undesirable
skin effects attributed to cosmetic products. Consumer
reports showed that, in 38% (n = 494) of the cases, a
GP was consulted, implying that, annually, some 60 000
people in The Netherlands have an undesirable reaction
attributable to a cosmetic product. This is probably an
underestimation, because, in most cases, consumers do
not consult a GP or dermatologist, as most reactions
to cosmetic products are not severe, and disappear
soon after discontinuation of product use or after self-
treatment. However, consumers tend not to consult a
health professional even in cases of severe reactions. This
was indicated by a survey conducted at the request of
the Council of Europe in 2002–2005, showing that only
25–36% of people consult a GP if they experience highly
undesirable effects (6). The problem of undesirable effects
caused by cosmetic products is also underestimated, as
not every consumer is willing to report. To encourage
consumers to register undesirable effects, the CESES
project included a public awareness campaign, and each
media activity resulted in a direct increase in the number
of consumer reports.
A considerable number of people reported suffering
from an underlying allergy (20–39%) or a skin disease
(15–26%). These percentages are higher than reported
in the review of Wijnhoven et al. (23), possibly because
undesirable reactions to cosmetic products occur more
© 2013 John Wiley & Sons A/S
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frequently in patients with contact dermatitis or atopic
dermatitis (24). Moreover, people with an underlying
allergy or skin diseasemay also bemore inclined to report
undesirable effects on a website or seek medical attention
for further diagnosis.
The four most frequently reported cosmetic prod-
ucts were moisturisers, make-up, hair care products,
and soaps. Eye contour creams and non-perfumed oint-
ments constituted a specific subcategory of moisturisers
frequently registered by consumers and dermatologists,
respectively. Reports on moisturisers as a frequent cause
of undesirable effects are in line with the findings of other
cosmetovigilance systems (3, 6, 15, 17, 25–27). Most
undesirable effects ofmake-up concerned products for use
on or around the eyes and eyelids, which is in accordance
with other studies (24, 25).
As in other monitoring systems (3, 15, 17, 21, 24,
26), most undesirable effects were reported in women,
and this may be explained by the fact that women have
a high level of use of cosmetic products. In addition,
cosmetic products are often associated with products
such as make-up and skin cream, which are principally
used by women. Women are also more inclined to seek
medical attention and report health effects. Furthermore,
skin sensitisation and allergic contact dermatitis aremore
common in women (24, 26, 28, 29).
Of the patients patch testedwith the European baseline
series, the largest group (23%, n = 34) reacted to
isothiazolinones [MI or amixture of methylchloroisothia-
zolinone (MCI) and MI]. In 47% of these cases (16/34),
isothiazolinones were found to be the causal link between
the undesirable effect and the cosmetic product (Table 2).
MI, MCI and MCI/MI are potent sensitisers that are
widely used as preservatives in consumer products,
such as household cleaning products and cosmetic
products (23, 30, 31). The MCI/MI mixture (in a 3:1
combination) is permitted in cosmetic products up to a
maximum concentration of 0.0015%, and themaximum
permitted concentration of MI is 0.01% (1, 32). Since
2005, MCI/MI has often been replaced by MI alone
to reduce the prevalence of allergic contact dermatitis
caused by preservatives. As MI is a weaker preservative,
there usually needs to be another preservative, such as
phenoxyethanol,which is a rare allergen that is especially
used in skin care products (9). Recent case reports have
shown that MI alone can also induce allergic contact
dermatitis (31, 33, 34). The combination of allergenic
potency and frequent use in consumer products means
that MI and MCI/MI exposure carries a high risk for the
development of allergic contact dermatitis (35) especially
occupational dermatitis (31, 35). The results of the CESES
project and other studies (31, 34, 36–38) indicate a need
for close monitoring of the prevalence of MI-induced
allergic contact dermatitis. A recent study (39) showed
that a considerable number of patients reacted to an MI
concentration 20 times lower than permitted in cosmetic
products, and has recommended that the permitted MI
concentration in cosmetic products be reduced under the
Cosmetic Products Directive (76/768/EEC).
Fragrances are known allergenic substances present
in cosmetic products (9, 27, 40). Estimates show that
1.0–4.2% of the general population are sensitised to
fragrance ingredients, and fragranceallergy is, inaddition
to allergy to preservatives, a frequent cause of undesirable
effects of cosmetic products (41, 42). In the CESES project,
21% of patients subjected to a patch test reacted to
fragrance mix I, and 18% had a positive reaction to
fragrance mix II. It is known that false-positive reactions
to fragrance mix I and fragrance mix II are common.
In this regard, it is important to note here that, in most
cases of a positive reaction to fragrancemix I or fragrance
mix II, further breakdown testing with a fragrance series,
including the separate ingredients of the two mixes, was
performed. The diagnosis of fragrance allergy was based
not only on a positive reaction to fragrance mix I or
fragrance mix II, but also on the medical history and the
reaction to individual fragrance ingredients andmarkers.
In the CESES pilot project, 6% (n = 9) of patients tested
with theEuropeanbaseline serieswere found tobepositive
for the fragrance ingredient HICC. Recently, the Scientific
CommitteeonConsumerSafety (SCCS) reported thatHICC
has been shown to be the cause of a considerable number
of cases of allergic contact dermatitis since 1999 (43). On
the basis of this information, the SCCS recommended that
the use of HICC in consumer products be discontinued.
Interestingly, even though fragrances are used in
a variety of cosmetic products, including moisturisers,
soaps, deodorants, and perfumes, there were few reports
of the product category perfumes containing fragrance
ingredients as a potential cause of an adverse reaction.
Possibly, consumers are aware of the allergenic potential
of perfumes, and spray the product on their clothes rather
than directly on the skin. Another explanation is that the
exposure via scented creams and lotions is higher than
that via perfumes.
The positive reaction to CAPB in 21% (n = 32) of
patients tested with the European baseline series should
be interpretedwith caution. CAPB is a synthetic detergent
that is widely used in cosmetic products such as sham-
poos, conditioners, and make-up removers (44, 45). The
sensitizing properties of CAPB are subject to a scientific
debate. A recent study found that patch testing with
CAPB produced a large number of false-positive reactions
to CAPB (46).
© 2013 John Wiley & Sons A/S
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The results of patch tests with specific product ingredi-
ents showed that 3 of 15 positively tested patients devel-
oped a reaction to co-polymers/cross-polymers, including
C30–38 olefin/isopropyl maleate/MA copolymer used
in a sunscreen. Co-polymers/cross-polymers are used in
cosmetic products becauseof their film-forming, viscosity-
increasing, skin-conditioning, emulsion-stabilizing and
hair-fixing properties (32, 47). However, the aller-
genic properties of these substances are as yet
unknown. The CESES results are in line with a
recent study (48) that described several cases of aller-
gic contact dermatitis attributable to a co-polymer in a
sunscreen product. The sensitising component in co-
polymers/cross-polymers has not been identified, and
further investigation of their allergenic potential is
required (7, 47).
The positive test results for nickel sulfate, MDBGN
and cobalt chloride should be interpreted with caution,
because the use of these allergens in cosmetic products
is prohibited. The positive results could be the conse-
quence of historical exposure. However, traces of nickel
may occur in decorative cosmetics and application tools,
such as mascara brushes. A more likely cause of nickel
allergy is jewellery. In 2007, a prohibition on MDBGN
in cosmetics was incorporated in the Cosmetic Products
Directive (76/768/EEC), and, since June 2008, products
containing MDBGN have no longer been on the mar-
ket. However, MDBGN exposure via cosmetic products
may result from the use of products manufactured before
the prohibition. MDBGN is still used in other consumer
products.
Itwouldhavebeen interesting to further investigate the
collected consumer reports by offering diagnostic patch
testing. Unfortunately, the current study setup did not
allow for this. In a further study, this option could be
considered.
Overall, the CESES pilot project has been shown to
provide valuable information on the symptoms and the
localisation of undesirable effects of cosmetic products.
Moreover, the project has contributed to the identification
of products and product ingredients that cause undesir-
able effects. In our opinion, a cosmetovigilance system is
an important tool to obtain information on the safety of
cosmetic ingredients that could be used to assess whether
current EU legislation on cosmetics provides adequate
protection.
On the basis of the experience gained and the positive
evaluation of CESES as a tool for monitoring undesirable
effects of cosmetic products, the Netherlands Food and
Consumer Product Safety Authority and the Ministry of
Health,Welfare and Sport have decided to continue regis-
trationofundesirableeffects in2012.During this time, the
potential for establishing a European cosmetovigilance
network will be explored to stimulate further exchange of
informationbetweencosmetovigilancesystems inEurope.
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